Your Shopping Cart Is Empty
| Report Code: A03251 | Aug 2021 | Pages: 234 | ||
| Tables: 119 | Charts: 47 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Cough Remedies Market
Request Now !The global Cough Remedies market size was valued at $7084.5 million in 2020, and is projected to reach $9911.2 million by 2030, registering a CAGR of 3.4% from 2021 to 2030. Cough is an immune response of the body to combat with antigens or any foreign bodies that is harmful after entering respiratory system. Progression of which may lead to complete congestion in lungs. The most common causes of cough are tobacco use, postnasal drip, asthma, and Gastroesophageal reflux disease (GERD). There are various types of conditions that are susceptible to cause chronic cough if left untreated. Major signs and symptoms include runny or stuffy nose, frequent throat clearing & sore throat, hoarseness, wheezing, and shortness of breath. Other causes of cough include chronic obstructive pulmonary disease (COPD), pneumonia, bronchiectasis, nonasthmatic eosinophilic bronchitis bronchiolitis, lung cancer, idiopathic pulmonary fibrosis, and usage of blood pressure drugs.
Surge in geriatric population, who are more prone to cough and cold, increase in vehicle pollution, surge in demand for over-the-counter products, increase in development of R&D activities, and growth in awareness about advanced medicines are anticipated to aid the cough remedies market generate higher revenue in the coming years. Increase in number of testing and research facilities mainly in the field of biotechnology and pharmaceutical companies contribute toward significant market growth during the forecast period
However, strict regulations regarding efficiency of cough remedies hinder the cough remedies market growth. Moreover, surge in incidences of conditions attacking respiratory system poses lucrative opportunities for the growth of the market in coming years.
The World Health Organization (WHO) on January 30, 2021 declared COVID-19 outbreak a public health emergency of international concern. Cough remedies can be used in management of cough caused as a symptom after getting exposed to COVID-19. However, workforce shortages as well as resource limitations, owing to COVID-19 is expected to negatively impact growth of the industry during the forecast period. In addition, rise in strict government regulations regarding lockdowns led to decrease in growth of the market. Moreover, need of the hour is to bring up newer products that can help combat with the advent of COVID-19 virus. There has been a steep growth in research activities to bring new products to cure cough caused by the virus, which is expected to propel growth of cough remedies during the forecast period.
The global cough remedies market is segmented into product type, age group, distribution channel, and region. On the basis of product type, the market is categorized into expectorants, antihistamines, bronchodilators, decongestants, and antibiotics. Depending on age group, it is segregated into pediatric and adult. By distribution channel, it is classified into retail pharmacy, hospital pharmacy, and online pharmacy. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
On the basis of product type, the expectorants segment is expected to gain highest revenue during the forecast period, owing to surge in incidences of respiratory diseases such as pneumonia, chronic obstructive pulmonary syndrome, and other infectious diseases that can cause congestion in lungs and create cough in chest walls. In addition, dry cough requires expectorants to help remove it from chest wall easily and rise in dry cough incidences is hence expected to propel growth of the segment during the forecast period.
Depending on age group, the adult segment is anticipated to gain fastest CAGR during the forecast period and increase in incidences of chronic respiratory in adults, which require cough remedies propels growth of the market. In addition, advancements in cough remedies that can be used for adults are expected to propel growth in demand for cough remedies and hence aid the segment to gain traction in next few years. Growth in investments for research and development of novel products for therapeutics of chronic cough in adults who are aged 65 years and above helps the segment generate higher revenue.
By distribution channel, the hospital pharmacy segment dominated the global market in 2020, and is expected to continue this trend in the coming years. This is attributed to increase in number of outpatients and inpatients preferring hospital pharmacy and higher investments of hospitals for getting improved products as cough remedies. Furthermore, surge in adoption of newer products for research purposes in diagnostic laboratories leads to growth of the segment of the cough remedies market.
The key players profiled in this report include Astrazeneca PLC (Astrazeneca), Bayer Ag, GlaxoSmithKline PLC, Johnson & Johnson, Novartis AG, Pfizer, Inc., Prestige Brands, Inc., Procter & Gamble, Reckitt Benckiser Group PLC., and Sun Pharmaceuticals Industries Limited.
Key Benefits For Stakeholders
Key Market Segments
By Product Type
By Age Group
By Distribution Channel
By Region
Cough Remedies Market Report Highlights
| Aspects | Details |
|---|---|
| By PRODUCT TYPE |
|
| By AGE GROUP |
|
| By DISTRIBUTION CHANNEL |
|
| By Region |
|
| Key Market Players | GLAXOSMITHKLINE PLC, ASTRAZENECA PLC, SUN PHARMACEUTICALS INDUSTRIES LIMITED, PROCTER & GAMBLE (P&G), JOHNSON & JOHNSON, PFIZER, INC., .PRESTIGE BRANDS INC., .BAYER AG, Novartis International AG, Reckitt Benckiser Group plc. |
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in prevalence of respiratory diseases
3.5.1.2.Upsurge in geriatric population with weaker immune systems
3.5.1.3.Surge in strategic moves adopted by major players
3.5.2.Restraint
3.5.2.1.Stringent regulations for treatment of chronic cough
3.5.3.Opportunity
3.5.3.1.Outbreak of novel viruses attacking respiratory system
3.5.4.Impact analysis
3.6.COVID-19 Impact analysis on the cough remedies market
CHAPTER 4:COUGH REMEDIES MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Expectorants
4.2.1.Market size and forecast
4.2.2.Market analysis, by country
4.3.Bronchodilators and cough suppressants
4.3.1.Market size and forecast
4.3.2.Market analysis, by country
4.4.Decongestants
4.4.1.Market size and forecast
4.4.2.Market analysis, by country
4.5.Antibiotics
4.5.1.Market size and forecast
4.5.2.Market analysis, by country
CHAPTER 5:COUGH REMEDIES MARKET, BY AGE GROUP
5.1.Overview
5.1.1.Market size and forecast
5.2.Pediatric
5.2.1.Market size and forecast
5.2.2.Market analysis, by country
5.3.Adult
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
CHAPTER 6:COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL
6.1.Overview
6.1.1.Market size and forecast
6.2.Retail Pharmacy
6.2.1.Market size and forecast
6.2.2.Market analysis, by country
6.2.3.Market size and forecast, by route of age group
6.3.Hospital pharmacy
6.3.1.Market size and forecast
6.3.2.Market analysis, by country
6.3.3.Market size and forecast, by route of age group
6.4.Online pharmacy
6.4.1.Market size and forecast
6.4.2.Market analysis, by country
6.4.3.Market size and forecast, by route of age group
CHAPTER 7:COUGH REMEDIES MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.2.1.U.S.
7.2.2.1.1.U.S. cough remedies market, by product type
7.2.2.1.2.U.S. cough remedies market, by age group
7.2.2.1.3.U.S. cough remedies market, by distribution channel
7.2.2.2.Canada
7.2.2.2.1.Canada cough remedies market, by product type
7.2.2.2.2.Canada cough remedies market, by age group
7.2.2.2.3.Canada cough remedies market, by distribution channel
7.2.2.3.Mexico
7.2.2.3.1.Mexico cough remedies market, by product type
7.2.2.3.2.Mexico cough remedies market, by age group
7.2.2.3.3.Mexico cough remedies market, by distribution channel
7.2.3.North America market size and forecast, by product type
7.2.4.North America market size and forecast, by age group
7.2.5.North America market size and forecast, by product type
7.2.6.North America market size and forecast, by distribution channel
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country
7.3.2.1.Germany
7.3.2.1.1.Germany cough remedies market, by product type
7.3.2.1.2.Germany cough remedies market, by age group
7.3.2.1.3.Germany cough remedies market, by distribution channel
7.3.2.2.France
7.3.2.2.1.France cough remedies market, by product type
7.3.2.2.2.France cough remedies market, by age group
7.3.2.2.3.France cough remedies market, by distribution channel
7.3.2.3.UK
7.3.2.3.1.UK cough remedies market, by product type
7.3.2.3.2.UK cough remedies market, by age group
7.3.2.3.3.UK cough remedies market, by distribution channel
7.3.2.4.Italy
7.3.2.4.1.Italy cough remedies market, by product type
7.3.2.4.2.Italy cough remedies market, by age group
7.3.2.4.3.Italy cough remedies market, by distribution channel
7.3.2.5.Spain
7.3.2.5.1.Spain cough remedies market, by product type
7.3.2.5.2.Spain cough remedies market, by age group
7.3.2.5.3.Spain cough remedies market, by distribution channel
7.3.2.6.Rest of Europe
7.3.2.6.1.Rest of Europe cough remedies market, by product type
7.3.2.6.2.Rest of Europe cough remedies market, by age group
7.3.2.6.3.Rest of Europe cough remedies market, by distribution channel
7.3.4.Europe market size and forecast, by product type
7.3.5.Europe market size and forecast, by age group
7.3.6.Europe market size and forecast, by distribution channel
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.2.1.Japan
7.4.2.1.1.Japan cough remedies market, by product type
7.4.2.1.2.Japan cough remedies market, by age group
7.4.2.1.3.Japan cough remedies market, by distribution channel
7.4.2.2.China
7.4.2.2.1.China cough remedies market, by product type
7.4.2.2.2.China cough remedies market, by age group
7.4.2.2.3.China cough remedies market, by distribution channel
7.4.2.3.Australia
7.4.2.3.1.Australia cough remedies market, by product type
Source: Primary & Secondary Research and AMR Analysis
7.4.2.3.2.Australia cough remedies market, by age group
7.4.2.3.3.Australia cough remedies market, by distribution channel
7.4.2.4.India
7.4.2.4.1.India cough remedies market, by product type
7.4.2.4.2.India cough remedies market, by age group
7.4.2.4.3.India cough remedies market, by distribution channel
7.4.2.5.Rest of Asia-Pacific
7.4.2.5.1.Rest of Asia-Pacific cough remedies market, by product type
7.4.2.5.2.Rest of Asia-Pacific cough remedies market, by age group
7.4.2.5.3.Rest of Asia-Pacific cough remedies market, by distribution channel
7.4.3.Asia-Pacific market size and forecast, by product type
7.4.4.Asia-Pacific market size and forecast, by age group
7.4.5.Asia-Pacific market size and forecast, by distribution channel
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.2.1.Brazil
7.5.2.1.1.Brazil cough remedies market, by product type
Source: Primary & Secondary Research and AMR Analysis
7.5.2.1.2.Brazil cough remedies market, by age group
7.5.2.1.3.Brazil cough remedies market, by distribution channel
7.5.2.2.Saudi Arabia
7.5.2.2.1.Saudi Arabia cough remedies market, by product type
7.5.2.2.2.Saudi Arabia cough remedies market, by age group
7.5.2.2.3.Saudi Arabia cough remedies market, by distribution channel
7.5.2.3.South Africa
7.5.2.3.1.South Africa cough remedies market, by product type
7.5.2.3.2.South Africa cough remedies market, by age group
7.5.2.3.3.South Africa cough remedies market, by distribution channel
7.5.2.4.Rest of LAMEA
7.5.2.4.1.Rest of LAMEA cough remedies market, by product type
7.5.2.4.2.Rest of LAMEA cough remedies market, by age group
7.5.2.4.3.Rest of LAMEA cough remedies market, by distribution channel
7.5.4.LAMEA market size and forecast, by product type
7.5.5.LAMEA market size and forecast, by age group
7.5.6.LAMEA market size and forecast, by distribution channel
CHAPTER 8:COMPANY PROFILES
8.1.ASTRAZENECA PLC
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.BAYER AG
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.3.GLAXOSMITHKLINE PLC
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.JOHNSON & JOHNSON
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.5.Novartis International AG
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.6.PFIZER, INC.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.7.PRESTIGE BRANDS INC.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.8.PROCTER & GAMBLE (P&G)
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.9.Reckitt Benckiser Group plc.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.10.SUN PHARMACEUTICALS INDUSTRIES LIMITED
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
LIST OF TABLES
TABLE 01.GLOBAL COUGH REMEDIES MARKET BY PRODUCT TYPE, 2020–2030, ($MILLION)
TABLE 02.COUGH REMEDIES MARKET FOR EXPECTORANTS MARKET BY REGION 2020–2030, ($MILLION)
TABLE 03.COUGH REMEDIES MARKET FOR BRONCHODILATORS AND COUGH SUPPRESSANTSMARKET BY REGION 2020–2030, ($MILLION)
TABLE 04.COUGH REMEDIES MARKET FOR DECONGESTANTS MARKET BY REGION 2020–2030, ($MILLION)
TABLE 05.COUGH REMEDIES MARKET FOR ANTIBIOTICS MARKET BY REGION 2020–2030, ($MILLION)
TABLE 06.COUGH REMEDIES MARKET BY AGE GROUP, 2020–2030, ($MILLION)
TABLE 07.COUGH REMEDIES MARKET FOR PEDIATRIC MARKET BY REGION, 2020–2030, ($MILLION)
TABLE 08.COUGH REMEDIES MARKET FOR ADULT, BY REGION 2020–2030, ($MILLION)
TABLE 09.COUGH REMEDIES MARKET BY DISTRIBUTION CHANNEL, 2020–2030, ($MILLION)
TABLE 10.COUGH REMEDIES MARKET FOR RETAIL PHARMACY BY DISTRIBUTION CHANNEL 2020–2030, ($MILLION)
TABLE 11.COUGH REMEDIES MARKET FOR RETAIL PHARMACY, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 12.COUGH REMEDIES MARKET FOR HOSPITAL PHARMACY BY DISTRIBUTION CHANNEL 2020–2030, ($MILLION)
TABLE 13.COUGH REMEDIES MARKET FOR HOSPITAL PHARMACY, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 14.COUGH REMEDIES MARKET FOR ONLINE PHARMACY BY DISTRIBUTION CHANNEL 2020–2030, ($MILLION)
TABLE 15.COUGH REMEDIES MARKET FOR HOSPITAL PHARMACY, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 16.COUGH REMEDIES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 17.NORTH AMERICA COUGH REMEDIES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 18.U.S. COUGH REMEDIES MARKET BY PRODUCT TYPE, 2020–2030, ($MILLION)
TABLE 19.U.S. COUGH REMEDIES MARKET BY AGE GROUP, 2020–2030, ($MILLION)
TABLE 20.U.S. COUGH REMEDIES MARKET BY DISTRIBUTION CHANNEL, 2020–2030, ($MILLION)
TABLE 21.CANADA COUGH REMEDIES MARKET BY PRODUCT TYPE, 2020–2030, ($MILLION)
TABLE 22.CANADA COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 23.CANADA COUGH REMEDIES MARKET BY DISTRIBUTION CHANNEL, 2020–2030, ($MILLION)
TABLE 24.MEXICO COUGH REMEDIES MARKET BY PRODUCT TYPE, 2020–2030, ($MILLION)
TABLE 25.MEXICO COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 26.MEXICO COUGH REMEDIES MARKET BY DISTRIBUTION CHANNEL, 2020–2030, ($MILLION)
TABLE 27.NORTH AMERICA COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 28.NORTH AMERICA COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 29.NORTH AMERICA COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 30.NORTH AMERICA COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 31.EUROPE COUGH REMEDIES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 32.GERMANY COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 33.GERMANY COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 34.GERMANY COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 35.FRANCE COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 36.FRANCE COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 37.FRANCE COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 38.UK COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 39.UK COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 40.UK COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 41.ITALY COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 42.ITALY COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 43.ITALY COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 44.SPAIN COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 45.SPAIN COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 46.SPAIN COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 47.REST OF EUROPE COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 48.REST OF EUROPE COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 49.REST OF EUROPE COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 50.EUROPE COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 51.EUROPE COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 52.EUROPE COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 53.ASIA-PACIFIC COUGH REMEDIES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 54.JAPAN COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 55.JAPAN COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 56.JAPAN COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 57.CHINA COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 58.CHINA COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 59.CHINA COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 60.AUSTRALIA COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 61.AUSTRALIA COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 62.AUSTRALIA COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 63.INDIA COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 64.INDIA COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 65.INDIA COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 66.REST OF ASIA-PACIFIC COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 67.REST OF ASIA-PACIFIC COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 68.REST OF ASIA-PACIFIC COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 69.ASIA-PACIFIC COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 70.ASIA-PACIFIC COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 71.ASIA-PACIFIC COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 72.LAMEA COUGH REMEDIES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 73.BRAZIL COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 74.BRAZIL COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 75.BRAZIL COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 76.SAUDI ARABIA COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 77.SAUDI ARABIA COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 78.SAUDI ARABIA COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 79.SOUTH AFRICA COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 80.SOUTH AFRICA COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 81.SOUTH AFRICA COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 82.REST OF LAMEA COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 83.REST OF LAMEA COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 84.REST OF LAMEA COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 85.LAMEA COUGH REMEDIES MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 86.LAMEA COUGH REMEDIES MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 87.LAMEA COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 88.ASTRAZENECA: COMPANY SNAPSHOT
TABLE 89.ASTRAZENECA: OPERATING SEGMENTS
TABLE 90.ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 91.ASTRAZENECA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 92.BAYER: COMPANY SNAPSHOT
TABLE 93.BAYER: OPERATING SEGMENTS
TABLE 94.BAYER: PRODUCT PORTFOLIO
TABLE 95.GLAXOSMITHKLINE: COMPANY SNAPSHOT
TABLE 96.GLAXOSMITHKLINE: OPERATING SEGMENTS
TABLE 97.GLAXOSMITHKLINE: PRODUCT PORTFOLIO
TABLE 98.GLAXOSMITHKLINE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99.J&J: COMPANY SNAPSHOT
TABLE 100.J&J: OPERATING BUSINESS SEGMENTS
TABLE 101.J&J: PRODUCT PORTFOLIO
TABLE 102.NOVARTIS: COMPANY SNAPSHOT
TABLE 103.NOVARTIS: OPERATING SEGMENT
TABLE 104.NOVARTIS: PRODUCT PORTFOLIO
TABLE 105.PFIZER: COMPANY SNAPSHOT
TABLE 106.PFIZER: OPERATING SEGMENT
TABLE 107.PFIZER: PRODUCT TYPE PORTFOLIO
TABLE 108.PRESTIGE: COMPANY SNAPSHOT
TABLE 109.PRESTIGE: OPERATING SEGMENTS
TABLE 110.PRESTIGE: PRODUCT PORTFOLIO
TABLE 111.P&G: COMPANY SNAPSHOT
TABLE 112.P&G: OPERATING BUSINESS SEGMENTS
TABLE 113.P&G: PRODUCT PORTFOLIO
TABLE 114.RECKITT: COMPANY SNAPSHOT
TABLE 115.RECKITT: OPERATING BUSINESS SEGMENTS
TABLE 116.RECKITT: PRODUCT PORTFOLIO
TABLE 117.SUN PHARMA: COMPANY SNAPSHOT
TABLE 118.SUN PHARMA: OPERATING SEGMENT
TABLE 119.SUN PHARMA: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.COUGH REMEDIES MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07.HIGH BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.HIGH INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF COUGH REMEDIES MARKET, FOR EXPECTORANTS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF COUGH REMEDIES MARKET, FOR BRONCHODILATORS AND COUGH SUPPRESSANTS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF COUGH REMEDIES MARKET, FOR DECONGESTANTS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF COUGH REMEDIES MARKET, FOR ANTIBIOTICS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF COUGH REMEDIES MARKET, FOR PEDIATRIC, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF COUGH REMEDIES MARKET, FOR ADULT, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF COUGH REMEDIES MARKET, FOR RETAIL PHARMACY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF COUGH REMEDIES MARKET, FOR HOSPITAL PHARMACY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF COUGH REMEDIES MARKET, FOR ONLINE PHARMACY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22.ASTRAZENECA: REVENUE, 2018–2020 ($MILLION)
FIGURE 23.ASTRAZENECA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 24.BAYER: NET SALES, 2018–2020 ($MILLION)
FIGURE 25.BAYER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 26.BAYER: REVENUE SHARE BY REGION, 2020(%)
FIGURE 27.GLAXOSMITHKLINE: REVENUE, 2018–2020 ($MILLION)
FIGURE 28.GLAXOSMITHKLINE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 29.GLAXOSMITHKLINE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 30.J&J: NET SALES, 2018–2020 ($MILLION)
FIGURE 31.J&J: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32.J&J: REVENUE SHARE BY REGION, 2020(%)
FIGURE 33.NOVARTIS: NET SALES, 2018–2020 ($MILLION)
FIGURE 34.NOVARTIS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 35.NOVARTIS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 36.PFIZER: REVENUE, 2018–2020 ($MILLION)
FIGURE 37.PFIZER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38.PRESTIGE: NET SALES, 2019–2021 ($MILLION)
FIGURE 39.PRESTIGE: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 40.PRESTIGE: REVENUE SHARE BY REGION, 2021(%)
FIGURE 41.P&G: NET SALES, 2018–2020 ($MILLION)
FIGURE 42.P&G: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 43.P&G: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 44.RECKITT: NET SALES, 2018–2020 ($MILLION)
FIGURE 45.RECKITT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 46.SUN PHARMA: NET SALES, 2018–2020 ($MILLION
FIGURE 47.SUN PHARMA: REVENUE SHARE BY REGION, 2020 (%)
Cough remedies include medications that help combat with the immune response of cough and fights with antigens. In addition, rise in prevalence of respiratory diseases of various types mainly bacterial, fungal, and viral is expected to fuel growth of the market in the coming years. Furthermore, advent of unknown mutated microbes that are likely to cause chest infection or chronic cough has increased the need for research, and is expected to fuel the market growth during the forecast period. Rise in investments for development of medications to cure cough is expected to propel growth of the industry in next few years. In addition, advent of drug-resistant strains has opened newer avenues for the cough remedies market.
North America is expected to gain significant shares in 2020, owing to surge in healthcare spending on respiratory diseases. Furthermore, surge in geriatric population and multidrug resistance among adults and children boost need for novel drugs. This is expected to help the region generate high revenue in coming years. In addition, Asia-Pacific is anticipated to gain highest market share, owing to rise in patient population and increase in the spending on improvement of healthcare infrastructure.
A. Cough remedies are those medications that can help remove mucus or suppress the immune response and hence reduce the exaggerated cough.
A. Cough remedies are used to help reduce the coughing and remove mucus from the respiratory tract.
A. The total value of cough remedies market was $7084.5 million in 2020.
A. The forecast period in the report is from 2021-2030.
A. The market value of cough remedies market in 2030 was $9911.2 million.
A. The base year calculated in the report is 2020.
A. Increased demand for the cough remedies and rise in respiratory tract diseases will drive the market over the near future according to the KOLs.
A. The market has drawn the interest of the healthcare industry, owing to increasing prevalence of ashtma, COPD and other respiratory diseases, rise in advancements in cough remedies, and growing awareness among civil population regarding cough remedies
A. By product type, the Bronchodilators and cough suppressants segment holds the maximum market share.
A. The market in LAMEA is expected to register lucrative CAGR of 4.5% and highest revenue over the forecast period owing to presence of large population base, increase in awareness regarding cough remedies, and rise in disposable income
Start reading instantly.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report